Dubai BIOSERA (France) signed an exclusive distribution agreement with Alliance Global to bring their highest quality serum portfolio to AGBL’s market. “BIOWEST’s diverse serum and cell culture media products will complement the AGBL Cell Biology range of products and support our customers in academia, governmental and industrials markets.” said Fatima Kakal, Product Manager Cell and […]
New Assay Expands Application Range of Agilent Seahorse XF Technology SANTA CLARA, Calif. Agilent Technologies Inc. (NYSE: A) today announced the Agilent Seahorse XF Real-Time ATP Rate Assay Kit, a new product that will enable biologists to enhance their understanding of how live-cells function in real-time. The Seahorse XF Real-Time ATP Rate Assay Kit enables […]
Multi-Electrode Array (MEA) Offers New Route for Type 2 Diabetes Drug Development and Ability to Elucidate Beta Cell PathophysiologyHOLLISTON, Mass.2 — Multi Channel Systems (MCS), a subsidiary of Harvard Bioscience, Inc., launched its Beta Cell-System, a new, non-invasive beta cell screening system for diabetes research. The Beta Cell-System leverages MCS’s multi electrode array (MEA) technology to […]
AMSBIO has introduced a new range of over 400 Isogenic cell lines that provide a reliable and efficient alternative to traditional human disease models. Isogenic cell lines can be used to model any disease with a genetic foundation. Cancer is one such disease for which isogenic human disease cell line models have been widely used. […]
DARMSTADT, GERMANY Highly sensitive optical system based on patented technology unique to Merck’s Amnis® flow cytometers Configurable, 7-laser capacity to meet researchers’ evolving needs Laser upgrades quickly performed in lab with no downtime Merck, a leading science and technology company, today launched its new CellStream™ benchtop flow cytometry system, a compact, customizable flow cytometer that uses […]
MINNEAPOLIS — Bio-Techne, a family of brands providing a unique portfolio of products and services for basic and clinical research, has a leading role supporting autophagy research. Autophagy (or “self-eating”) is an important basic cellular process by which cell components are degraded by lysosomes or vacuoles and recycled. Autophagy plays a crucial role in human […]
VANCOUVER, British Columbia–STEMCELL Technologies, Canada’s largest biotechnology company, today announced a $45 million joint funding agreement between the Governments of Canada and British Columbia to help the company build a state-of-the-art advanced manufacturing facility. The funding agreement will accelerate the Vancouver company’s rapidly scaling business of providing cutting-edge reagents and tools to support life science […]
New Cell Sorter Extends BD’s Robust Portfolio of Flow Cytometry Research Solutions FRANKLIN LAKES, N.J. — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of the BD FACSymphony™ S6 cell sorter, which will be on display at the 33rd Congress of the International Society for Advancement of Cytometry next week in Prague. The new […]
Hamburg The major aim during the multi-passage cultivation of pluripotent stem cells (PSCs) is to preserve their differentiation and growth potential. Here, the proper selection of a defined culture system that consists of a growth surface and culture medium is crucial. The commonly used biological coating materials for PSC expansion are based on either mouse […]
Dansky Ullmann joins the Company as MaxCyte prepares for clinical testing of its first cell therapy drug candidate Brings more than 25 years of experience in clinical oncology and drug development Gaithersburg, Maryland: MaxCyte, the global cell-based medicines and life sciences company, announced today that it has appointed Claudio Dansky Ullmann, MD, a 25+-year expert in […]
Pay Invoice
Latest Blogs
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
